000119312512275021txt 20120619 000119312512275021hdrsgml 20120619 20120619131126 accession number 000119312512275021 conformed submission type sc 14d9a public document count 1 filed date 20120619 date change 20120619 subject company company data company conformed name kensey nash corp central index key 0001002811 standard industrial classification surgical medical instrument apparatus 3841 irs number 363316412 state incorporation de fiscal year end 1231 filing value form type sc 14d9a sec act 1934 act sec file number 00548201 film number 12914505 business address street 1 735 pennsylvania drive city exton state pa zip 19341 business phone 6105947156 mail address street 1 735 pennsylvania drive city exton state pa zip 19341 filed by company data company conformed name kensey nash corp central index key 0001002811 standard industrial classification surgical medical instrument apparatus 3841 irs number 363316412 state incorporation de fiscal year end 1231 filing value form type sc 14d9a business address street 1 735 pennsylvania drive city exton state pa zip 19341 business phone 6105947156 mail address street 1 735 pennsylvania drive city exton state pa zip 19341 sc 14d9a 1 d369428dsc14d9ahtm amendment no 2 schedule 14d9 amendment no 2 schedule 14d9 united state security exchange commission washington dc 20549 schedule 14d9 rule 14d101 solicitationrecommendation statement section 14d4 security exchange act 1934 amendment no 2 kensey nash corporation name subject company kensey nash corporation name person filing statement common stock par value 0001 per share title class security 490057106 cusip number class security joseph w kaufmann chief executive officer kensey nash corporation 735 pennsylvania drive exton pennsylvania 19341 484 7132100 name address telephone number person authorized receive notice communication behalf person filing statement copy to david r shevitz mark d wood katten muchin rosenman llp 525 west monroe street suite 1900 chicago illinois 606613693 312 9025200 ¨ check box filing relates solely preliminary communication made commencement tender offer introduction amendment no 2 amends supplement solicitationrecommendation statement schedule 14d9 initially filed security exchange commission the “sec” may 21 2012 amended amendment no 1 thereto filed sec june 6 2012 a amended “schedule 14d9” kensey nash corporation delaware corporation the “company” relating tender offer biomedical acquisition corporation “purchaser” delaware corporation indirect whollyowned subsidiary koninklijke dsm nv corporation organized netherlands “parent” “dsm” purchase issued outstanding share common stock par value 0001 per share company including associated series junior participating preferred stock purchase right “common stock” purchase price 3850 per share net seller cash the “offer price” tender offer disclosed tender offer statement schedule together exhibit thereto may amended andor supplemented “schedule to” filed purchaser parent sec may 21 2012 upon term subject condition set forth offer purchase dated may 21 2012 a may amended andor supplemented “offer purchase” related letter transmittal a may amended andor supplemented “letter transmittal” and together offer purchase “offer” offer purchase letter transmittal filed exhibit a1a a1b schedule to respectively incorporated reference schedule 14d9 capitalized term used otherwise defined herein shall meaning ascribed term schedule 14d9 except otherwise set forth below information schedule 14d9 remains unchanged incorporated reference relevant item amendment no 2 amendment no 2 filed reflect certain update reflected below item 8 additional information item 8 schedule 14d9 hereby amended supplemented adding following immediately subsection captioned “cautionary note regarding forwardlooking statements” “expiration offer offer expired 1200 midnight new york city time end monday june 18 2012 the “expiration time” according depositary offer expiration time 7151081 share common stock validly tendered properly withdrawn pursuant offer 276900 tendered pursuant notice guaranteed delivery represent approximately 82 total outstanding share common stock and approximately 79 total outstanding share common stock excluding share tendered notice guaranteed delivery purchaser accepted payment expects promptly pay for share common stock validly tendered properly withdrawn prior expiration time pursuant offer purchaser stated intends exercise topup option pursuant company issue sell purchaser price per share equal offer price number share common stock that added number share common stock owned dsm purchaser immediately prior exercise constitutes one share 90 number share common stock outstanding after giving effect exercise result purchase share common stock offer exercise topup option purchaser dsm sufficient number share common stock effect shortform merger applicable delaware law without meeting vote company’s stockholder accordance merger agreement dsm purchaser stated intend effect shortform merger purchaser company next day effective time merger share common stock other share held treasury company owned dsm subsidiary dsm company held stockholder properly demand perfect appraisal right dgcl tendered pursuant offer cancelled converted right receive amount cash equal offer price addition upon completion merger common stock cease traded nasdaq global select market june 19 2012 dsm issued press release announcing expiration result offer copy press release filed exhibit a5d schedule 14d9 incorporated herein reference” item 9 exhibit item 9 schedule 14d9 hereby amended supplemented adding following exhibit exhibit no description a5d press release dated june 19 2012 incorporated reference exhibit a5i amendment no 2 schedule filed dsm purchaser june 19 2012 signature due inquiry best knowledge belief certify information set forth statement true complete correct kensey nash corporation date june 19 2012 by s joseph w kaufmann name joseph w kaufmann title president chief executive officer secretary000119312512275021txt 20120619 000119312512275021hdrsgml 20120619 20120619131126 accession number 000119312512275021 conformed submission type sc 14d9a public document count 1 filed date 20120619 date change 20120619 subject company company data company conformed name kensey nash corp central index key 0001002811 standard industrial classification surgical medical instrument apparatus 3841 irs number 363316412 state incorporation de fiscal year end 1231 filing value form type sc 14d9a sec act 1934 act sec file number 00548201 film number 12914505 business address street 1 735 pennsylvania drive city exton state pa zip 19341 business phone 6105947156 mail address street 1 735 pennsylvania drive city exton state pa zip 19341 filed by company data company conformed name kensey nash corp central index key 0001002811 standard industrial classification surgical medical instrument apparatus 3841 irs number 363316412 state incorporation de fiscal year end 1231 filing value form type sc 14d9a business address street 1 735 pennsylvania drive city exton state pa zip 19341 business phone 6105947156 mail address street 1 735 pennsylvania drive city exton state pa zip 19341 sc 14d9a 1 d369428dsc14d9ahtm amendment no 2 schedule 14d9 amendment no 2 schedule 14d9 united state security exchange commission washington dc 20549 schedule 14d9 rule 14d101 solicitationrecommendation statement section 14d4 security exchange act 1934 amendment no 2 kensey nash corporation name subject company kensey nash corporation name person filing statement common stock par value 0001 per share title class security 490057106 cusip number class security joseph w kaufmann chief executive officer kensey nash corporation 735 pennsylvania drive exton pennsylvania 19341 484 7132100 name address telephone number person authorized receive notice communication behalf person filing statement copy to david r shevitz mark d wood katten muchin rosenman llp 525 west monroe street suite 1900 chicago illinois 606613693 312 9025200 ¨ check box filing relates solely preliminary communication made commencement tender offer introduction amendment no 2 amends supplement solicitationrecommendation statement schedule 14d9 initially filed security exchange commission the “sec” may 21 2012 amended amendment no 1 thereto filed sec june 6 2012 a amended “schedule 14d9” kensey nash corporation delaware corporation the “company” relating tender offer biomedical acquisition corporation “purchaser” delaware corporation indirect whollyowned subsidiary koninklijke dsm nv corporation organized netherlands “parent” “dsm” purchase issued outstanding share common stock par value 0001 per share company including associated series junior participating preferred stock purchase right “common stock” purchase price 3850 per share net seller cash the “offer price” tender offer disclosed tender offer statement schedule together exhibit thereto may amended andor supplemented “schedule to” filed purchaser parent sec may 21 2012 upon term subject condition set forth offer purchase dated may 21 2012 a may amended andor supplemented “offer purchase” related letter transmittal a may amended andor supplemented “letter transmittal” and together offer purchase “offer” offer purchase letter transmittal filed exhibit a1a a1b schedule to respectively incorporated reference schedule 14d9 capitalized term used otherwise defined herein shall meaning ascribed term schedule 14d9 except otherwise set forth below information schedule 14d9 remains unchanged incorporated reference relevant item amendment no 2 amendment no 2 filed reflect certain update reflected below item 8 additional information item 8 schedule 14d9 hereby amended supplemented adding following immediately subsection captioned “cautionary note regarding forwardlooking statements” “expiration offer offer expired 1200 midnight new york city time end monday june 18 2012 the “expiration time” according depositary offer expiration time 7151081 share common stock validly tendered properly withdrawn pursuant offer 276900 tendered pursuant notice guaranteed delivery represent approximately 82 total outstanding share common stock and approximately 79 total outstanding share common stock excluding share tendered notice guaranteed delivery purchaser accepted payment expects promptly pay for share common stock validly tendered properly withdrawn prior expiration time pursuant offer purchaser stated intends exercise topup option pursuant company issue sell purchaser price per share equal offer price number share common stock that added number share common stock owned dsm purchaser immediately prior exercise constitutes one share 90 number share common stock outstanding after giving effect exercise result purchase share common stock offer exercise topup option purchaser dsm sufficient number share common stock effect shortform merger applicable delaware law without meeting vote company’s stockholder accordance merger agreement dsm purchaser stated intend effect shortform merger purchaser company next day effective time merger share common stock other share held treasury company owned dsm subsidiary dsm company held stockholder properly demand perfect appraisal right dgcl tendered pursuant offer cancelled converted right receive amount cash equal offer price addition upon completion merger common stock cease traded nasdaq global select market june 19 2012 dsm issued press release announcing expiration result offer copy press release filed exhibit a5d schedule 14d9 incorporated herein reference” item 9 exhibit item 9 schedule 14d9 hereby amended supplemented adding following exhibit exhibit no description a5d press release dated june 19 2012 incorporated reference exhibit a5i amendment no 2 schedule filed dsm purchaser june 19 2012 signature due inquiry best knowledge belief certify information set forth statement true complete correct kensey nash corporation date june 19 2012 by s joseph w kaufmann name joseph w kaufmann title president chief executive officer secretary